https://www.selleckchem.com/pr....oducts/Erlotinib-Hyd
92). The two groups had no significant difference in the rates of initial non-operative management (50% (AC) vs 56% (non-AC), p = 0.3)) or failure of non-operative management (7 vs 4%, p = 0.16). AC patients were more likely to be managed initially with angiography (36 vs 20%, p = 0.001) while non-AC patients with surgery (24% vs 13%, p = 0.04). There was no significant difference in LOS and mortality. Conclusion The use of anticoagulation did not result in a difference in outcomes among patients with spleen and/or liver
Like
Comment
Share
